Michal

​

Michal graduated in chemistry and biology at Tel-Aviv University in 2008 and conducted her PhD studies under the supervision of Prof. Edit Tshuva at the Hebrew University of Jerusalem, working on the design of peptidic models for copper metallochaperones, both for mechanistic investigation and as drug candidates for Wilson’s disease.

After graduating in 2015, she spent three years at ETH Zurich, where she worked as a Marie Curie postdoctoral fellow in the group of Prof. Helma Wennemers on the development of peptide-coated platinum nanoparticles as antitumor agents.

At the beginning of 2019, Michal opened her research group at the department of chemistry of the University of Zurich, supported by the Swiss National Science Foundation, where she works on the development of new candidates for chelation therapy and environmental remediation.